glp 1 rhabdomyolysis PDF) associated with the use of tirzepatide GLP-1-based therapies for type 2

Plan ahead by requesting a travel letter from your pharmacy confirming the medication and its storage needs

Take home message Despite not being prominently featured in medication guides, reports from Second Nature members and online forums suggest that cold sensitivity is a real and common experience among Mounjaro users

Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies

As these therapies become household names, the role of digital engagement grows more powerful

Eyes (NAION): EMA concluded in June 2025 that NAION is a very rare side effect of semaglutide (1 in 10,000)